SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancersJie Mei(Nanjing Medical University), Yongmei Yin(Nanjing Medical University)iScienceJanuary 23, 202310.1016/j.isci.2023.106027Cited by 21SaveCiteExport RISWatch citationsRelated PapersMDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9|PLoS ONE|2013|47A DAAM1 3′-UTR SNP mutation regulates breast cancer metastasis through affecting miR-208a-5p-DAAM1-RhoA axis|Cancer Cell International|2019|46The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer|British Journal of Cancer|2023|13